Anzeige
Meldung des Tages: Diese Zahlen lügen nicht: Wie Tiefsee-Knollen den landbasierten Bergbau übertreffen könnten

Idorsia News

Aktie
WKN:  A2DTEB ISIN:  CH0363463438 US-Symbol:  IDRSF Branche:  Biotechnologie Land:  Schweiz
4,056 €
-0,024 €
-0,59%
12:40:28 Uhr
Depot/Watchlist
Marktkapitalisierung *
858,56 Mio. €
Streubesitz
55,25%
KGV
-0,58
Index-Zuordnung
-

Idorsia News

25.06.25 - GlobeNewswire
Idorsia launches repurchase offer for its 2025 and 2028 convertible bonds
Ad hoc announcement pursuant to Art. 53 LR
23.06.25 - GlobeNewswire
Idorsia’s QUVIVIQ expands into China as Simcere receives NDA approval – Idorsia and Simcere update their licensing agreement
Ad hoc announcement pursuant to Art. 53 LR
10.06.25 - GlobeNewswire
Idorsia announces the appointment of Srishti Gupta, MD as CEO to ensure the long-term success of Idorsia
Ad hoc announcement pursuant to Art. 53 LR
06.06.25 - GlobeNewswire
Idorsia publishes invitations to bondholder meetings
Ad hoc announcement pursuant to Art. 53 LR
28.05.25 - GlobeNewswire
Shareholders vote in favor of all proposals by the Board at Idorsia’s Annual General Meeting 2025
Allschwil, Switzerland – May 28, 2025 At today’s Annual General Meeting (AGM) of Idorsia Ltd (SIX: IDIA) held in Basel, Switzerland, shareholders voted convincingly in favor of all ...
21.05.25 - GlobeNewswire
New funds secured – allowing the commercial ramp-up of QUVIVIQ to accelerate Idorsia’s path to profitability
Ad hoc announcement pursuant to Art. 53 LR
02.05.25 - GlobeNewswire
Idorsia issues invitation to the 2025 Annual General Meeting of Shareholders
Allschwil, Switzerland – May 2, 2025 Idorsia Ltd (SIX: IDIA) today issued the invitation to the upcoming Annual General Meeting (AGM) of Shareholders on behalf of the Board of ...
30.04.25 - GlobeNewswire
Idorsia announces financial results for the first quarter 2025 – QUVIVIQ taking off in Europe and TRYVIO REMS removal increases the value of this outstanding asset
Ad hoc announcement pursuant to Art. 53 LR
29.04.25 - GlobeNewswire
New data with daridorexant assessing the transition from night to day in insomnia disorder published in Sleep Medicine
Daridorexant improved sleep maintenance throughout the entire night, including the last quarter, while also improving next-​morning sleepiness. Daridorexant improved next-...

Newssuche

Videos

newspaper
16.04.26 +2,80%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »